Pharma Journalist 8769 posts 0 comments

The European Commission has granted approval to ENFLONSIA, a preventive therapy developed by Merck & Co., for protecting newborns and infants against respiratory syncytial virus…
Read More...

Piramal Pharma Solutions and Ajinomoto Bio-Pharma Services have announced a strategic collaboration aimed at strengthening capabilities in the rapidly growing field of antibody-drug…
Read More...

Interna Therapeutics has entered into a new research collaboration with Daiichi Sankyo to explore next-generation approaches to intracellular drug delivery, marking another step forward…
Read More...

Nucleai and Sirona Dx have announced a strategic partnership aimed at delivering a fully integrated spatial proteomics solution to pharmaceutical and biotechnology companies. The…
Read More...

Terremoto Biosciences has secured $108 million in a Series C financing round, strengthening its position in the race to develop next-generation targeted therapies for cancer and rare…
Read More...

Aligos Therapeutics has entered into an exclusive licensing agreement with Xiamen Amoytop Biotech Co., Ltd. to develop and commercialize its investigational hepatitis B treatment,…
Read More...

Boehringer Ingelheim and Zai Lab have announced a new clinical collaboration aimed at advancing a novel dual-targeting strategy for difficult-to-treat cancers. The partnership will…
Read More...

Sana Biotechnology has announced a strategic collaboration with Mayo Clinic to accelerate the development of SC451, an investigational cell therapy aimed at transforming treatment for…
Read More...

CrossBridge Bio, Inc., a pre-clinical biotech firm specializing in next-generation antibody-drug conjugates (ADCs), has agreed to be acquired by Eli Lilly and Company in a deal valued…
Read More...

As New Approach Methodologies (NAMs) and microphysiological systems (MPS) continue to gain momentum across drug development, the imperative facing industry scientists is increasingly…
Read More...